Skip to main content

Day: November 15, 2024

Teck Named as One of Canada’s Top 100 Employers

VANCOUVER, British Columbia, Nov. 15, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) has been named one of Canada’s Top 100 Employers for the eighth consecutive year by Mediacorp Canada’s Top Employers program, which recognizes companies for exceptional human resource programs and innovative workplace policies. “Our people are committed to providing essential resources the world needs in a responsible manner that supports communities, the economy, and a healthy environment,” said Jonathan Price, President and CEO. “It is our employees who drive Teck’s growth, and we are committed to fostering workplaces where they can be their best and build rewarding, fulfilling careers.” Editors at Mediacorp, Canada’s largest publisher of employment periodicals, grade employers on eight criteria,...

Continue reading

Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) — Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company received formal notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s failure to timely file the Form 20-F for the fiscal year ended December 31, 2023 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company no longer satisfied Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”) and its securities are therefore subject to suspension and delisting unless the Company timely requests a hearing before and a further stay of any suspension action at least pending the ultimate conclusion of the hearings process from the Nasdaq Hearings...

Continue reading

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that data from an interim analysis of the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC) will be featured during a poster session at the upcoming 25th Annual Meeting of the Society of Urologic Oncology (SUO) taking place December 4, 2024 to December 6, 2024, in Dallas, Texas. The presentation will include safety data featured in the abstract published today on the SUO website, as well as updated safety and new efficacy data from approximately 20 enrolled patients, the majority of whom are six-month evaluable. ADVANCED-2 (NCT05951179) is a Phase 2 open-label...

Continue reading

RecycLiCo Announces Annual General Meeting to be Held on December 12, 2024

SURREY, British Columbia, Nov. 15, 2024 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), TSX.V: AMY, OTCQB: AMYZF, FSE: ID4, a pioneer in sustainable lithium-ion battery recycling technology, is pleased to announce that its annual general meeting (the “AGM”) will be held on Thursday, December 12, 2024, at 1:00 p.m. (Vancouver time) at the Executive Hotel Vancouver Airport, Executive Board Room, 7311 Westminster Hwy, Richmond, BC, V6X 1A3. Meeting Details and Proxy MaterialsShareholders are encouraged to review the proxy materials, which have been mailed to all shareholders of record. Proxy materials are also available for download on the Company’s website at www.recyclico.com/agm and on SEDAR+ for those who did not receive them via mail. Shareholders are reminded to submit their proxies or voting...

Continue reading

ERES REIT Declares November 2024 Monthly Distribution

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the November 2024 monthly cash distribution of €0.01 per Unit and Class B LP Unit (the “November Distribution”), being equivalent to €0.12 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the “Unitholders”) of record on November 29, 2024, with payment on December 16, 2024. The Euro-denominated distribution will be paid in Canadian dollars based on the exchange rate on the date of payment (estimated C$0.01477 per Unit and Class B LP Unit). Registered Unitholders will be provided with an option to elect to receive such distribution in Euros rather than Canadian dollars. If no such election is made, registered...

Continue reading

CAPREIT Announces November 2024 Distribution

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) announced today its November 2024 monthly distribution in the amount of $0.125 per Unit (or $1.50 on an annualized basis). The November 2024 distribution will be payable on December 16, 2024 to Unitholders of record at the close of business on November 29, 2024. CAPREIT is Canada’s largest publicly traded provider of quality rental housing. As at September 30, 2024, CAPREIT owns approximately 63,400 residential apartment suites, townhomes and manufactured home community sites, including approximately 15,400 suites and sites classified as assets held for sale, that are well-located across Canada and the Netherlands, with a total fair value of approximately $16.9 billion, including approximately $1.9 billion...

Continue reading

Nobel Announces Results of AGM

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX–V: NBLC; OTCQB: NBTRF) (the “Company” or “Nobel”) is pleased to report that the nominees listed in the management proxy circular dated October 4, 2024 (the “Circular”) for the annual and special meeting of shareholders of Nobel held on November 15, 2024 (the “Meeting”) were elected as directors of the Company.  Shareholders at the Meeting also approved the appointment of the Company’s auditors, the Company’s stock option plan and the Company’s restricted share unit and deferred unit plan. Details of these plans are included in the Circular which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca. Nobel management would like to thank shareholders for their participation and continuing support. About Nobel Nobel Resources is a Canadian resource...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for December 13, 2024

CALGARY, Alberta, Nov. 15, 2024 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to November 2024 of $0.11 per common share is to be paid on December 13, 2024, for shareholders of record on November 30, 2024. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact: Jean-Paul LachancePresident...

Continue reading

Halcones Precious Metals Announces AGM Results

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Halcones Precious Metals Corp. (TSXV: HPM) (the “Company” or “Halcones”) is pleased to report that the nominees listed in the management proxy circular dated October 4, 2024 (the “Circular”) for the annual and special meeting of shareholders of Halcones held on November 15, 2024 (the “Meeting”) were elected as directors of the Company.  The appointment of each of the nominees to the Company’s board was approved by more than 99% of the votes cast at the Meeting.  Shareholders at the Meeting also approved the appointment of the Company’s auditors, the Company’s stock option plan and the Company’s restricted share unit and deferred unit plan. Details of these plans are included in the Circular which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca. Halcones management...

Continue reading

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration

WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has notified The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to file its own Form 25 (Notification of Removal of Listing) with the U.S. Securities and Exchange Commission (the “SEC”) to complete the previously-disclosed process to delist the Company’s common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Market in advance of Nasdaq’s anticipated filing of a Form 25 with the SEC. As previously disclosed, the Common Stock was suspended from trading on Nasdaq as of October 3, 2024, pursuant to a final delisting notice sent to the Company by the Listing Qualifications Department of Nasdaq due to the Company’s inability to regain compliance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.